Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is Mantech International Corp (MANT) A Good Stock To Buy ?

The market has been volatile in the fourth quarter as the Federal Reserve continued its rate hikes to normalize the interest rates. Small cap stocks have been hit hard as a result, as the Russell 2000 ETF (IWM) has underperformed the larger S&P 500 ETF (SPY) by nearly 7 percentage points. SEC filings and hedge fund investor letters indicate that the smart money seems to be paring back their overall long exposure since summer months, and the funds’ movements is one of the reasons why the major indexes have retraced. In this article, we analyze what the smart money thinks of Mantech International Corp (NASDAQ:MANT) and find out how it is affected by hedge funds’ moves.

Mantech International Corp (NASDAQ:MANT) has experienced a decrease in support from the world’s most elite money managers in recent months. MANT was in 10 hedge funds’ portfolios at the end of December. There were 14 hedge funds in our database with MANT positions at the end of the previous quarter. Our calculations also showed that mant isn’t among the 30 most popular stocks among hedge funds.

In the 21st century investor’s toolkit there are several indicators stock traders can use to appraise publicly traded companies. Two of the less known indicators are hedge fund and insider trading sentiment. We have shown that, historically, those who follow the top picks of the top money managers can beat the broader indices by a solid margin (see the details here).

John Overdeck of Two Sigma

Let’s analyze the recent hedge fund action encompassing Mantech International Corp (NASDAQ:MANT).

Hedge fund activity in Mantech International Corp (NASDAQ:MANT)

At the end of the fourth quarter, a total of 10 of the hedge funds tracked by Insider Monkey held long positions in this stock, a change of -29% from the previous quarter. On the other hand, there were a total of 19 hedge funds with a bullish position in MANT a year ago. So, let’s find out which hedge funds were among the top holders of the stock and which hedge funds were making big moves.

No of Hedge Funds with MANT Positions

Among these funds, Citadel Investment Group held the most valuable stake in Mantech International Corp (NASDAQ:MANT), which was worth $2.9 million at the end of the third quarter. On the second spot was Horizon Asset Management which amassed $1.3 million worth of shares. Moreover, Two Sigma Advisors, AQR Capital Management, and GLG Partners were also bullish on Mantech International Corp (NASDAQ:MANT), allocating a large percentage of their portfolios to this stock.

Because Mantech International Corp (NASDAQ:MANT) has faced a decline in interest from the aggregate hedge fund industry, we can see that there were a few fund managers who sold off their positions entirely in the third quarter. Intriguingly, Paul Marshall and Ian Wace’s Marshall Wace LLP dropped the largest investment of the “upper crust” of funds tracked by Insider Monkey, totaling about $3 million in stock, and Matthew Hulsizer’s PEAK6 Capital Management was right behind this move, as the fund dumped about $0.8 million worth. These transactions are interesting, as aggregate hedge fund interest was cut by 4 funds in the third quarter.

Let’s check out hedge fund activity in other stocks – not necessarily in the same industry as Mantech International Corp (NASDAQ:MANT) but similarly valued. We will take a look at Select Medical Holdings Corporation (NYSE:SEM), Avalara, Inc. (NYSE:AVLR), The Navigators Group, Inc (NASDAQ:NAVG), and Bottomline Technologies (de), Inc. (NASDAQ:EPAY). All of these stocks’ market caps are similar to MANT’s market cap.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
SEM 19 153809 0
AVLR 14 535698 -1
NAVG 17 243042 0
EPAY 17 74972 -2
Average 16.75 251880 -0.75

View table here if you experience formatting issues.

As you can see these stocks had an average of 16.75 hedge funds with bullish positions and the average amount invested in these stocks was $252 million. That figure was $8 million in MANT’s case. Select Medical Holdings Corporation (NYSE:SEM) is the most popular stock in this table. On the other hand Avalara, Inc. (NYSE:AVLR) is the least popular one with only 14 bullish hedge fund positions. Compared to these stocks Mantech International Corp (NASDAQ:MANT) is even less popular than AVLR. Hedge funds dodged a bullet by taking a bearish stance towards MANT. Our calculations showed that the top 15 most popular hedge fund stocks returned 24.2% through April 22nd and outperformed the S&P 500 ETF (SPY) by more than 7 percentage points. Unfortunately MANT wasn’t nearly as popular as these 15 stock (hedge fund sentiment was very bearish); MANT investors were disappointed as the stock returned 7.5% and underperformed the market. If you are interested in investing in large cap stocks with huge upside potential, you should check out the top 15 most popular stocks) among hedge funds as 13 of these stocks already outperformed the market this year.

Disclosure: None. This article was originally published at Insider Monkey.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.